ASML LEGAL UPDATE: A Lawsuit has been Filed Against ASML Holding N.V. for Securities Fraud – Contact BFA Law before Court Deadline (NASDAQ:ASML)
NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against ASML Holding N.V. ASML and certain of the Company’s senior executives for potential violations of the federal securities laws.
If you invested in ASML, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/asml-holding-nv.
Investors have until January 13, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ASML securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned City of Hollywood Firefighters’ Pension Fund v. ASML Holding N.V., et al., No. 24-cv-8664.
What is the Lawsuit About?
ASML is a leading supplier to the semiconductor industry, providing photolithography machines to chipmakers that are used in the semiconductor fabrication process.
The complaint alleges that ASML repeatedly represented to shareholders that new export controls on semiconductor technology announced by the Dutch government would not have a material effect on ASML’s financial outlook, and that ASML was on a path to recovery in its sales.
On October 15, 2024, ASML announced earnings significantly lower than expectations. The Company attributed this to a market that was “taking longer to recover” and admitted that “[i]t now appears the recovery is more gradual than previously expected.” On this news, the price of the Company’s stock fell 16%, from a closing price of $872.27 per share on October 14, 2024, to $730.43 per share on October 15, 2024.
Then, during the accompanying earnings call with investors on October 16, 2024, the Company attributed the poor earnings results to “a reflection of the slow recovery in the traditional [semiconductor] end markets as customers remain cautious in the current environment.” The Company also disclosed that the decline in ASML’s sales to China would also negatively impact the Company’s gross margins. On this news, the price of the Company’s stock fell 6.4%, from a closing price of $730.43 per share on October 15, 2024, to $683.52 per share on October 16, 2024.
Click here if you suffered losses: https://www.bfalaw.com/cases-investigations/asml-holding-nv.
What Can You Do?
If you invested in ASML you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
https://www.bfalaw.com/cases-investigations/asml-holding-nv
Or contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
https://www.bfalaw.com/cases-investigations/asml-holding-nv
Attorney advertising. Past results do not guarantee future outcomes.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Bank of America bets on long-term growth in Mexico due to 'nearshoring', despite Trump tariff threat
By Aida Pelaez-Fernandez
MEXICO CITY (Reuters) – Bank of America is bullish on its future in Mexico, according to the head of the bank’s unit in the country, and stands to benefit from the so-called “nearshoring” trend even after threats of tariffs on exports to the U.S. by President-elect Donald Trump.
WHY IT’S IMPORTANT
Trump’s threat earlier this week to slap tariffs on Mexico and Canada has roiled markets and clouded the horizon for investments by multinational firms into the region.
The three countries are part of a regional trade agreement known as the USMCA, which is up for review in 2026. The neighboring nations, particularly the U.S. and Mexico, are heavily reliant on imports and exports from the other country.
KEY QUOTES
“It will be very difficult for uncertainties, either internal or external effects to alter or modify the opportunities that we see in Mexico,” said Bank of America’s Mexico head, Emilio Romano, in a press briefing.
“We believe that the nearshoring or friendshoring phenomenon will not be reversed,” he said, referring to the trend in which large multinationals have moved operations to Latin America’s No. 2 economy.
“Mexico will not deviate from this North American economic integration, there is no turning back.”
BY THE NUMBERS
Bank of America expects to double its revenue and client volume in Mexico within the next five years, Romano said.
The firm’s client base should grow from 400 to 800, according to the executive. In Mexico, BofA offers institutional banking services and does not serve individual clients.
Romano declined to provide more detail about the bank’s revenue outlook.
WHAT’S NEXT
Trump’s tariff threats will continue to generate market volatility, Romano said. However, he cautioned that they were likely a bargaining strategy by Trump to kick off trade negotiates and unlikely to actually be imposed.
(Reporting by Aida Pelaez-Fernandez; Editing by Anthony Esposito, Kylie Madry and Michael Perry)
EMERGE Reports Strong Q3 2024 Results
GMS Growth Accelerates to 10%. 2nd Consecutive Quarter of Positive Organic Revenue Growth. Improved Profitability.
TORONTO, Nov. 28, 2024 /CNW/ – EMERGE Commerce Ltd. ECOM (“EMERGE” or the “Company“) today announced results for its three months ended September 30, 2024. Copies of the interim financial statements and MD&A are available on the Company’s profile on SEDAR at www.sedar.com.
Q3 2024 Financial Highlights
- Q3 GMS1 accelerated by 10% to $7.4M compared to $6.8M in Q3 2023
- Q3 Revenue increased by 5% to $4.6M compared to $4.4M in Q3 2023. Excluding Carnivore Club, a brand that is actively eliminating loss-making revenue, EMERGE revenue growth was 8%, driven by truLOCAL and the golf business
- Q3 Gross Profit increased by 6% to $1.8M compared to $1.7M in Q3 2023
- Q3 Gross Margin improved to 39.3% compared to 38.9% in Q3 2023
- Q3 Adjusted EBITDA1 improved to $(0.28M) compared to $(0.56M) in Q3 2023
- Q3 Net loss from Continuing Operations improved to $(0.74M) compared to $(0.78M)
- Cash on hand at September 30, 2024 was $1.6M
Ghassan Halazon, Founder and CEO, EMERGE commented, “Despite Q3 historically being our most seasonal quarter of the year, GMS, the sales volume transacted across our sites, accelerated to 10% growth YoY, our highest growth rate all year. We achieved our second consecutive quarter of positive organic revenue growth. Both truLOCAL and our golf brands, UnderPar and JustGolfStuff, achieved improved YoY results, combining for 8% organic revenue growth. Once again, we delivered materially improved metrics, including YoY growth in revenue, gross profit, and Adjusted EBITDA. EMERGE 2.0, the centralized strategy we shifted to earlier this year, whereby EMERGE management directly operates and optimizes a more focused set of brands, rather than oversees middle management on a decentralized basis across a variety of verticals, is continuing to yield encouraging results, as demonstrated by our topline acceleration and improved bottom line year-to-date. Special thanks to our resilient and determined team, Board, shareholders and trusted partners as we deliver another growth quarter, and look to build on this momentum in the final quarter of the year.”
Outlook
Q4 and the peak holiday shopping season is generally EMERGE’s strongest quarter of the year overall. The Company continues to execute towards a return-to-growth plan in 2024, with a substantially improved profitability profile and reduced overall debt levels.
In Q3 and early Q4, EMERGE actioned certain cost reductions in relation to the Company’s more streamlined strategy that amount to approximately $500,000 annually. These savings will partially be reflected in Q4, and fully be reflected in Q1 2025 onwards.
In addition, the recent interest rate cuts, as well as the highly anticipated upcoming rate reductions, are expected to result in meaningful cash savings for the business.
Top Priorities
The Company’s top priorities in the near-term are to i) continue to drive organic growth, ii) extract further operational efficiencies to drive profitability, and iii) opportunistically explore avenues to enhance cash flow and reduce interest expense.
Conference Call
Management will host a conference call on Thursday, November 28 at 9:00 am ET to discuss its third quarter results. To access the conference call, please dial (416) 945-7677 or (888) 699-1199 and provide conference ID 79080.
Alternatively, the conference call can be accessed online at: https://app.webinar.net/37Ao90x9G2v
Selected Financial Highlights
The tables below set out selected financial information and should be read in conjunction with the Company’s consolidated financial statements and MD&A for the three months ended September 30, 2024, which are available on SEDAR.
Three months |
Three months |
Nine months ended |
Nine months |
||
2024 $ |
2023 $ |
2024 $ |
2023 $ |
||
Gross Merchandise Sales1 |
7,417,799 |
6,762,633 |
23,492,832 |
22,379,499 |
|
Total revenue |
4,596,215 |
4,371,920 |
14,799,166 |
14,443,430 |
|
Adjusted EBITDA1 |
(280,639) |
(557,915) |
(453,155) |
(1,429,638) |
|
Net (loss) income from continuing operations |
(738,887) |
(777,173) |
(1,392,808) |
(4,945,075) |
|
Net (loss) income2 |
(730,186) |
349,497 |
(793,568) |
(3,735,037) |
|
Basic and diluted (loss) per share from |
(0.01) |
(0.01) |
(0.01) |
(0.05) |
1 Non-GAAP Financial Measure. Refer to section “Non-GAAP Financial Measures” for additional information. |
Results from WholesalePet, BattlBox, and WagJag have been reclassified to discontinued operations.
The following table highlights Adjusted EBITDA and a reconciliation of the Company’s reported results to its adjusted measures:
Three months |
Three months |
Nine months |
Nine months |
|
2024 $ |
2023 $ |
2024 $ |
2023 $ |
|
Net (loss) income |
(730,186) |
349,497 |
(793,568) |
(3,735,037) |
Add back: |
||||
Finance costs |
267,209 |
860,946 |
1,066,372 |
2,778,346 |
Income taxes |
(184,585) |
(672,531) |
(318,963) |
(1,439,578) |
Amortization |
48,809 |
478,941 |
167,999 |
2,066,115 |
EBITDA |
(598,753) |
1,016,853 |
121,840 |
(330,154) |
Share-based compensation |
71,357 |
28,167 |
125,992 |
143,731 |
Transaction cost |
42 |
63,487 |
101,631 |
267,544 |
Foreign exchange and other losses (gains) |
255,416 |
(539,752) |
(203,378) |
2,512 |
Fair value change in contingent |
– |
– |
– |
(303,233) |
Net loss (income) from discontinued |
(8,701) |
(1,126,670) |
(599,240) |
(1,210,038) |
Adjusted EBITDA |
(280,639) |
(557,915) |
(453,155) |
(1,429,638) |
The following table highlights GMS and a reconciliation of the Company’s reported results to its adjusted measures:
Three months |
Three months |
Nine months |
Nine months |
|
2024 $ |
2023 $ |
2024 $ |
2023 $ |
|
Revenue |
4,596,215 |
4,371,920 |
14,799,166 |
14,443,430 |
Adjusted for: |
||||
Merchant costs deducted from net revenue |
3,047,845 |
2,478,336 |
9,412,272 |
8,475,791 |
Sales added to deferred revenue and value |
1,731,705 |
1,339,824 |
5,524,555 |
4,654,201 |
Deferred and other adjustments to revenue |
(1,863,899) |
(1,356,220) |
(5,899,238) |
(5,105,459) |
Advertising revenue |
(94,067) |
(71,227) |
(343,923) |
(88,464) |
GMS |
7,417,799 |
6,762,633 |
23,492,832 |
22,379,499 |
About EMERGE
EMERGE (TSXV: ECOM) is a premium e-commerce brand portfolio in Canada and the U.S. Our subscription and marketplace e-commerce properties provide our members with access to unique offerings across grocery and golf verticals. Our grocery businesses include truLOCAL.ca, our premium meat subscription brand, and Carnivore Club, our artisanal meat brand. Our golf businesses include UnderPar, our discounted experiences brand, and JustGolfStuff, our golf products & apparel brand.
To learn more visit https://www.emerge-commerce.com/
Follow EMERGE:
LinkedIn | Twitter | Instagram | Facebook
Cautionary notice
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Non-GAAP Measures
This press release makes reference to certain non-GAAP measures. These non-GAAP measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing a further understanding of results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the financial information of the Company reported under IFRS. Gross Merchandise Sales (“GMS”), EBITDA, and Adjusted EBITDA should not be construed as alternatives to revenue or net income/loss determined in accordance with IFRS. GMS, EBITDA and Adjusted EBITDA do not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers.
GMS as defined by management is the total dollar value of customer purchases of goods and services, excluding applicable taxes and net of discounts and refunds. Management believes GMS provides a useful measure for the dollar volume of e-commerce transactions made through our platforms and an indicator for our business performance.
Earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA as defined by management means earnings before interest and financing costs, income taxes, depreciation and amortization, transaction costs, foreign exchange gains/losses, discontinued operations, unrealized gains/losses on contingent consideration and share-based compensation. Management believes that Adjusted EBITDA is a useful measure because it provides information about the operating and financial performance of EMERGE and its ability to generate ongoing operating cash flow to fund future working capital needs and fund future capital expenditures or acquisitions.
A reconciliation of the adjusted measures is included in the Company’s management discussion & analysis for the twelve months ended December 31, 2023 in the section “Non-GAAP Financial Measures” available through SEDAR at www.sedar.com.
Notice regarding forward-looking statements
This press release may contain certain forward-looking information and statements (“forward-looking information”) within the meaning of applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts” and other similar expressions. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, its securities, or financial or operating results (as applicable). Although the Company believes that the expectations reflected in forward-looking information in this press release are reasonable, such forward-looking information has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company’s control, including the risk factors discussed in the Company’s MD&A, Prospectus Supplement and Annual Information Form and are available through SEDAR at www.sedar.com. The forward-looking information contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
On Behalf of the Board
Ghassan Halazon
Director, President and CEO
SOURCE Emerge Commerce Ltd.
View original content: http://www.newswire.ca/en/releases/archive/November2024/28/c6988.html
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Rogers Sugar Reports Strong Results for Fourth Quarter and for Fiscal 2024, Driven by the Contribution of Both Business Segments
VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (“our,” “we”, “us” or “Rogers”) RSI today reported fourth quarter of fiscal 2024 results with consolidated adjusted EBITDA of $38.3 million and $141.6 million for the current quarter and the year, respectively.
“We are proud to report a third consecutive year of improved profitability, driven by better results in both our Sugar and Maple segments,” said Mike Walton, President and Chief Executive Officer of Rogers and Lantic Inc. “Our relentless focus on strategy and business execution in has resulted in significant growth in revenue, profitability and free cash flow.”
“We are taking actions to build our business for the future, including expanding our production and logistic capacity in Eastern Canada with our LEAP Project. Although the project is expected to cost more than initially estimated, it remains financially sound and will allow us to meet the expected increase in demand from our customers.” Mr. Walton added. “Looking ahead, we expect another year of strong financial performance in 2025, consistent with the long-term underlying demand growth in the North American sugar market, and the recent recovery in our Maple segment.”
Fourth Quarter 2024 Consolidated Highlights (unaudited) |
Q4 2024 | Q4 2023 | YTD 2024 | YTD 2023 |
Financials ($000s) | ||||
Revenues | 333,029 | 308,036 | 1,231,763 | 1,104,713 |
Gross margin | 49,732 | 41,192 | 175,872 | 165,726 |
Adjusted gross margin(1) | 50,070 | 40,193 | 191,423 | 155,331 |
Results from operating activities | 30,080 | 22,815 | 97,209 | 94,963 |
EBITDA(1) | 37,971 | 29,568 | 126,052 | 121,249 |
Adjusted EBITDA(1) | 38,309 | 28,569 | 141,603 | 110,854 |
Net earnings | 18,562 | 11,876 | 53,729 | 51,789 |
per share (basic) | 0.14 | 0.12 | 0.45 | 0.50 |
per share (diluted) | 0.13 | 0.09 | 0.41 | 0.44 |
Adjusted net earnings(1) | 18,819 | 11,283 | 66,660 | 44,494 |
Adjusted net earnings per share (basic)(1) | 0.14 | 0.11 | 0.56 | 0.42 |
Trailing twelve months free cash flow | 73,341 | 45,765 | 73,341 | 45,765 |
Dividends per share | 0.09 | 0.09 | 0.36 | 0.36 |
Volumes | ||||
Sugar (metric tonnes) | 204,540 | 215,500 | 753,333 | 795,307 |
Maple Syrup (thousand pounds) | 11,927 | 10,363 | 46,947 | 43,871 |
(1) See “Cautionary statement on Non-IFRS Measures” for definition and reconciliation to IFRS measures.
- Consolidated adjusted EBITDA(1) for the 2024 fiscal year was $141.6 million, up by 28% from the same period in 2023, mainly driven by a strong performance from both of our business segments.
- Consolidated adjusted net earnings for fiscal 2024 were $66.7 million or $0.56 per share, as compared to $44.5 million or $0.42 per share for the same period in 2023, largely driven by the strong performance of our Sugar and Maple segments.
- Consolidated revenues for fiscal year 2024 amounted to $1.2 billion, an increase of 12% as compared to last year, due mainly to higher average pricing for refining-related activities in the Sugar segment, as well as higher pricing and higher sales volume in the Maple segment, partially offset by lower sales volume in the Sugar segment.
- Consolidated adjusted EBITDA(1) for the fourth quarter was $38.3 million, representing an increase of $9.7 million as compared to the same period last year.
- Adjusted EBITDA(1) in the Sugar segment was $34.2 million for the fourth quarter of fiscal 2024, an increase of $10.6 million compared to the same period last year.
- Adjusted EBITDA(1) in the Maple segment for fiscal year 2024 was higher than last year by $4.8 million, largely driven by improved average selling prices and incremental sales volume.
- Free cash flow for the trailing 12 months ended September 28, 2024 was $73.3 million, an increase of $27.6 million from the same period last year, largely driven by higher consolidated adjusted EBITDA(1).
- In the fourth quarter of fiscal 2024, we distributed $0.09 per share to our shareholders for a total amount of $11.5 million.
- The construction phase of the Montréal portion of our expansion project aimed at enhancing the production and logistic capacity of our Eastern sugar refining operations in Montréal and Toronto (formerly referred to as the “Expansion Project” and now referred to as the “LEAP Project”) has begun. Orders for sugar refining equipment and other large production and logistic-related equipment have been placed with suppliers, with several pieces of equipment already on site. Based on the work performed in recent months, and considering the most recent data available, we now estimate the expected total project cost to range between $280 million and $300 million, representing an increase of 40% to 50% over the initial estimate.
- On November 27, 2024, the Board of Directors declared a quarterly dividend of $0.09 per share, payable on or before January 9, 2025.
(1) See “Non-IFRS Measures” for definition and reconciliation to IFRS measures
SUGAR SEGMENT
Fourth Quarter 2024 Sugar Highlights (unaudited) |
Q4 2024 | Q4 2023 | YTD 2024 | YTD 2023 |
Financials ($000s) | ||||
Revenues | 272,811 | 256,229 | 998,029 | 893,482 |
Gross margin | 43,150 | 35,512 | 150,860 | 144,397 |
Adjusted gross margin(1) | 44,390 | 33,722 | 167,431 | 136,022 |
Per metric tonne ($/ mt) (1) | 217 | 156 | 222 | 171 |
Administration and selling expenses | 9,305 | 7,703 | 40,502 | 33,250 |
Distribution costs | 7,079 | 7,414 | 25,494 | 24,637 |
Results from operating activities | 26,766 | 20,395 | 84,864 | 86,510 |
EBITDA(1) | 32,985 | 25,453 | 107,033 | 106,021 |
Adjusted EBITDA(1) | 34,225 | 23,663 | 123,604 | 97,646 |
Volumes (metric tonnes) | ||||
Total volume | 204,540 | 215,500 | 753,333 | 795,307 |
(1) See “Cautionary statement on Non-IFRS Measures” for definition and reconciliation to IFRS measures.
In the fourth quarter of 2024, revenues increased by $16.6 million, compared to the same period last year. The positive variance was driven mainly by higher contribution from refining-related activities, partially offset by lower sales volume.
In the fourth quarter of fiscal 2024, sugar volume totaled approximately 204,500 metric tonnes, a decrease of approximately 5% or 11,000 metric tonnes compared to the same period last year, driven mainly by a slight reduction in North American demand and timing related to specific customers shipments.
Gross margin was $43.2 million for the current quarter and included a loss of $1.2 million for the mark-to-market of derivative financial instruments. For the same periods last year, gross margin was $35.5 million with a mark-to-market gain of $1.8 million.
Adjusted gross margin increased by $10.7 million in the current quarter compared to the same quarter last year mainly as a result of higher sugar sales margin from increased average pricing on sugar refining-related activities. This positive variance was partially offset by higher production costs mainly driven by increased maintenance activities and market-based inflationary pressures on costs, along with the unfavourable impact of lower sales volume. On a per-unit basis, adjusted gross margin for the fourth quarter was $217 per metric tonne, as compared to $156 per metric tonne for the same period last year. The favourable variance was mainly due to increase in overall margin from improved selling prices, partially offset by higher production costs.
Results from operating activities for the fourth quarter of 2024 were $26.8 million, an increase of $6.4 million as compared to the same period last year. These results include gains and losses from the mark-to-market of derivative financial instruments.
EBITDA for the fourth quarter was $33.0 million, an increase of $7.5 million as compared to same period last year. These results include gains and losses from the mark-to-market of derivative financial instruments.
Adjusted EBITDA for the fourth quarter increased by $10.6 million compared to the same period last year, largely due to higher adjusted gross margin and lower distribution costs, partially offset by higher administration and selling expenses.
MAPLE SEGMENT
Fourth Quarter 2024 Maple Highlights (unaudited) |
Q4 2024 | Q4 2023 | YTD 2024 | YTD 2023 |
Financials ($000s) | ||||
Revenues | 60,218 | 51,807 | 233,734 | 211,231 |
Gross margin | 6,582 | 5,680 | 25,012 | 21,329 |
Adjusted gross margin(1) | 5,680 | 6,471 | 23,992 | 19,309 |
As a percentage of revenues (%) (1) | 9.4% | 12.5% | 10.3% | 9.1% |
Administration and selling expenses | 2,919 | 2,777 | 11,429 | 10,979 |
Distribution costs | 349 | 483 | 1,238 | 1,898 |
Results from operating activities | 3,314 | 2,420 | 12,345 | 8,453 |
EBITDA(1) | 4,986 | 4,115 | 19,019 | 15,228 |
Adjusted EBITDA(1) | 4,084 | 4,906 | 17,999 | 13,208 |
Volumes (thousand pounds) | ||||
Total volume | 11,927 | 10,363 | 46,947 | 43,871 |
(1) See “Cautionary statement on Non-IFRS Measures” section of this press release for definition and reconciliation to IFRS measures.
Revenues for the fourth quarter were $8.4 million higher than the same period last year due to improved average selling prices and an increase in sales volume.
Gross margin was $6.6 million for the three months ended in the current fiscal year and includes a gain of $0.9 million for the mark-to-market of derivative financial instruments. For the same period last year, gross margin was $5.7 million with a mark-to-market loss of $0.8 million.
Adjusted gross margin for the fourth quarter of fiscal 2024 was lower by $0.8 million. The negative variance was largely due to the net impact of non-recuring adjustments recorded in the last quarters of 2024 and 2023. Such adjustments were related to inventory valuation, purchase of maple syrup and packaging components, and had a negative impact in the last quarter of 2024 and a positive impact in the last quarter of 2023.
Adjusted gross margin percentage for the fourth quarter of 2024 was 9.4% as compared to 12.5% for the same quarter last year. The unfavourable variance was mainly related to lower gross margin.
Results from operating activities for the current quarter were $3.3 million, compared to $2.4 million in the same period last year. These results include gains and losses from the mark-to-market of derivative financial instruments.
EBITDA for the fourth quarter of 2024 amounted to $5.0 million, compared to $4.1 million for the same period last year. These results include gains and losses from the mark-to-market of derivative financial instruments.
Adjusted EBITDA for the current quarter of fiscal 2024 decreased by $0.8 million, due to lower gross margin.
LEAP PROJECT
On August 11, 2023, the Board of Directors of Lantic approved the LEAP Project, consisting of an investment in the expansion of its Eastern Canada capacity. LEAP is expected to provide approximately 100,000 metric tonnes of incremental refined sugar capacity to the growing Canadian market and includes sugar refining assets, along with logistic assets to increase the delivery capacity to the Ontario market. The total cost for the LEAP Project was initially estimated at $200 million, with an expected delivery date scheduled in the first half of fiscal 2026.
The planning and design phases associated with the LEAP Project are now mostly completed and the construction phase has begun. Site preparation and permitting processes are completed for the main construction site in Montréal. Detailed planning for the Toronto portion of the project is now completed. Orders for sugar refining equipment and other large production and logistic-related equipment have been placed with suppliers, with several pieces of equipment already on site.
In the second half of 2024, we identified incremental costs to the LEAP Project, primarily due to design additions driven by the complexity of the project, market-driven price increases for construction, and new safety regulations. Many of the incremental costs are related to challenges associated with the repurposing of a section of the Montréal building for the sugar refining portion of the LEAP Project. Following this assessment, we worked closely with our design and construction partners to fully assess the overall impact of such issues on the total cost of the LEAP Project. Based on the work performed in recent months, and considering the most recent data available, we now estimate the expected total project costs to range between $280 million and $300 million, representing an increase of 40% to 50% over the initial estimate.
The changes described above are also impacting the expected completion date for the LEAP Project. Based on our most recent analysis, we now anticipate the LEAP Project to be in-service at the end of fiscal 2026, representing a delay of approximately six months from the initial schedule.
We remain confident in the investment’s value, which is supported by the robust economic fundamentals of the sugar industry in Canada and in North America. We expect the strong demand seen in recent years, along with the related improved pricing in the market to largely off-set the unfavourable impact of the incremental cost, and the longer construction schedule for the LEAP Project.
We are funding the execution of the LEAP Project, including the expected incremental costs, with a combination of debt, equity and our existing revolving credit facility. In connection with the financing plan of the LEAP Project, RSI issued new common shares in the second quarter of 2024, for net proceeds of $112.5 million. In the second half of 2023, also in connection with the financing of the LEAP Project, Lantic entered into two secured loan agreements with Investissement Québec for up to $65 million. We anticipate drawing funds from the approved loans from Investissement Québec at the beginning of fiscal 2025. In the first quarter of fiscal 2024, to support the LEAP Project, we increased the amount available under our revolving credit facility by $75 million, to $340 million.
As at September 28, 2024, $53.8 million, including $1.7 million in interest costs, has been capitalized in construction in progress on the balance sheet for the LEAP Project. Thus far, most of the costs incurred are related to the design and planning phases of the project, the site preparation in Montréal and sugar refining, production, and logistic equipment ordered and received from suppliers. For fiscal 2024, $42.6 million has been capitalized in connection with the LEAP Project, while $11.2 million was capitalized in fiscal 2023.
See “Forward-Looking Statements” and “Risks and Uncertainties in the 2024 fourth quarter Management’s Discussion and Analysis”.
OUTLOOK
Following a strong performance in both of our business segments in 2024, we expect to deliver a strong financial performance in 2025. The continued strength in demand and pricing is expected to support organic growth for our Sugar business segment going forward. We also expect the recovery in our Maple segment in 2024 to set the pace for another strong year in 2025, as the overall maple market is showing growth.
Sugar Segment
We expect the Sugar segment to perform well in fiscal 2025. Underlying North American demand for sugar remains historically strong, despite a slight decrease over the last two quarters. Gross margin for the sugar segment for 2025 is expected to align with previous year, reflecting market-based price increases for sugar and sugar containing products, and should continue to have a positive impact on our financial results, allowing us to mitigate the expected increase in costs associated with our operations.
Our sales volume expectation for fiscal year 2025 is set at 800,000 metric tonnes, which is aligned with the initial 2024 expectations, excluding the impact of the labour disruption at the Vancouver plant. Overall, this would represent an increase of over 5% year over year. We expect to continue to prioritize domestic sales and to take advantage of export sales opportunities in fiscal 2025, with the objective to consistently meet our commitments to our customers.
The harvest period for our sugar beet facility in Taber was completed in early November and we have received the expected quantity of beets from the growers. We are currently in the processing stage of the 2024 sugar beet campaign, with expected completion by the end of February. Based on our early assessment, we anticipate the 2024 crop to deliver between 105,000 metric tonnes and 110,000 metric tonnes of beet sugar, consistent with our expectations. The volume expectation aligns with the acreage contracted with the ASBG and the expected volume of sugar beets we anticipated receiving.
Production costs and maintenance programs for our three production facilities are expected to increase moderately in 2025, as such related expenditures continue to be impacted by market-based increase in costs and annual wage increases for employees. For 2025, we plan to continue to perform the necessary maintenance activities to ensure a smooth production process to meet the needs of our customers. We remain committed to managing our costs responsibly to properly maintain our production assets and related facilities.
Distribution costs are expected to decrease slightly in 2025. These expenditures reflect the current market dynamics requiring the transfer of sugar produced between our refineries to meet demand from customers, and some of the costs associated with servicing customers with imported refined sugar pending the completion of our LEAP Project.
Administration and selling expenses are expected to be stable in 2025 as compared to 2024.
We anticipate our financing costs to be stable in fiscal 2025, as excess cash related to the timing of the equity financing portion of the LEAP project is providing a temporary increase in our available cash, which is mitigating the impact of a higher net interest rate on our credit facility. We have been able to partially mitigate the impact of recent increases in interest rates and energy costs through our multi-year hedging strategy. We expect our hedging strategy will continue to mitigate such exposure in fiscal 2025.
Spending on regular business capital projects is expected to decrease slightly in fiscal 2025 as compared to 2024. We anticipate spending between $25.0 million to $30.0 million on various initiatives. This capital spending estimate excludes expenditures relating to our LEAP Project, which are currently estimated to be approximately $122 million for fiscal 2025.
Maple Segment
We expect financial results in our Maple segment to continue to be strong in 2025, following the recovery seen over the last year. Throughout the recovery period, we focused on negotiating market-based price increases and optimizing our operations at all our plants through automation and continuous improvement initiatives.
The sales volume for fiscal 2025 is expected to grow moderately by 0.5 million lbs. The sales volume expectation reflects current market conditions, and the anticipated availability of maple syrup from the producers. The 2024 maple syrup crop was significantly better than anticipated and should support the current market demand, while also allowing for the partial replenishment of the reserve held by the Producteurs et Productrices Acéricoles du Québec (“PPAQ”). The reserve of PPAQ has been depleted in recent years from below average crops.
We expect to spend between $1 million and $1.5 million annually on capital projects for the Maple business segment. The main driver for the selected projects is improvement in productivity and profitability through automation.
See “Forward-Looking Statements” and “Risks and Uncertainties in the 2024 fourth quarter Management’s Discussion and Analysis “.
A full copy of Rogers fourth quarter 2024, including Management’s Discussion and Analysis and 2024 Audited Consolidated Financial Statements, can be found at www.LanticRogers.com.
CAUTIONARY STATEMENT REGARDING NON-IFRS MEASURES
In analyzing results, we supplement the use of financial measures that are calculated and presented in accordance with IFRS with a number of non-IFRS financial measures. A non-IFRS financial measure is a numerical measure of a company’s performance, financial position or cash flow that excludes (includes) amounts or is subject to adjustments that have the effect of excluding (including) amounts, that are included (excluded) in most directly comparable measures calculated and presented in accordance with IFRS. Non-IFRS financial measures are not standardized; therefore, it may not be possible to compare these financial measures with the non-IFRS financial measures of other companies having the same or similar businesses. We strongly encourage investors to review the audited consolidated financial statements and publicly filed reports in their entirety, and not to rely on any single financial measure.
We use these non-IFRS financial measures in addition to, and in conjunction with, results presented in accordance with IFRS. These non-IFRS financial measures reflect an additional way of viewing aspects of the operations that, when viewed with the IFRS results and the accompanying reconciliations to corresponding IFRS financial measures, may provide a more complete understanding of factors and trends affecting our business. Refer to “Non-IFRS measures” section at the end of the MD&A for the current quarter for additional information.
The following is a description of the non-IFRS measures we used in this press release:
- Adjusted gross margin is defined as gross margin adjusted for “the adjustment to cost of sales”, which comprises the mark-to-market gains or losses on sugar futures and foreign exchange forward contracts as shown in the notes to the consolidated financial statements and the cumulative timing differences as a result of mark-to-market gains or losses on sugar futures and foreign exchange forward contracts.
- Adjusted results from operating activities are defined as results from operating activities adjusted for the adjustment to cost of sales.
- EBITDA is defined as earnings before interest, taxes, depreciation and amortization.
- Adjusted EBITDA is defined as adjusted results from operating activities adjusted to add back depreciation and amortization expenses.
- Adjusted net earnings is defined as net earnings adjusted for the adjustment to cost of sales and the income tax impact on these adjustments.
- Adjusted gross margin rate per MT is defined as adjusted gross margin of the Sugar segment divided by the sales volume of the Sugar segment.
- Adjusted gross margin percentage is defined as the adjusted gross margin of the Maple segment divided by the revenues generated by the Maple segment.
- Adjusted net earnings per share is defined as adjusted net earnings divided by the weighted average number of shares outstanding.
- Free cash flow is defined as cash flow from operations excluding changes in non-cash working capital, mark-to-market and derivative timing adjustments, financial instruments non-cash amount, and includes deferred financing charges, funds received from stock options exercised, capital and intangible assets expenditures, net of value-added capital expenditures and capital expenditures associated to LEAP Project, and payments of capital leases.
In this press release, we discuss the non-IFRS financial measures, including the reasons why we believe these measures provide useful information regarding the financial condition, results of operations, cash flows and financial position, as applicable. We also discuss, to the extent material, the additional purposes, if any, for which these measures are used. These non-IFRS measures should not be considered in isolation, or as a substitute for, analysis of our results as reported under IFRS. Reconciliations of non-IFRS financial measures to the most directly comparable IFRS financial measures are as follows:
RECONCILIATION OF NON-IFRS FINANCIAL MEASURES TO IFRS FINANCIAL MEASURES
Q4 2024 | Q4 2023 | |||||
Consolidated results (In thousands of dollars) |
Sugar | Maple Products |
Total | Sugar | Maple Products |
Total |
Gross margin | 43,150 | 6,582 | 49,732 | 35,512 | 5,680 | 41,192 |
Total adjustment to the cost of sales(1) | 1,240 | (902) | 338 | (1,790) | 791 | (999) |
Adjusted gross margin | 44,390 | 5,680 | 50,070 | 33,722 | 6,471 | 40,193 |
Results from operating activities | 26,766 | 3,314 | 30,080 | 20,395 | 2,420 | 22,815 |
Total adjustment to the cost of sales(1) | 1,240 | (902) | 338 | (1,790) | 791 | (999) |
Adjusted results from operating activities | 28,006 | 2,412 | 30,418 | 18,605 | 3,211 | 21,816 |
Results from operating activities | 26,766 | 3,314 | 30,080 | 20,395 | 2,420 | 22,815 |
Depreciation of property, plant and equipment, amortization of intangible assets and right-of-use assets | 6,219 | 1,672 | 7,891 | 5,058 | 1,695 | 6,753 |
EBITDA(1) | 32,985 | 4,986 | 37,971 | 25,453 | 4,115 | 29,568 |
EBITDA(1) | 32,985 | 4,986 | 37,971 | 25,453 | 4,115 | 29,568 |
Total adjustment to the cost of sales(1) | 1,240 | (902) | 338 | (1,790) | 791 | (999) |
Adjusted EBITDA | 34,225 | 4,084 | 38,309 | 23,663 | 4,906 | 28,569 |
Net earnings | 18,562 | 11,876 | ||||
Total adjustment to the cost of sales(1) | 338 | (999) | ||||
Net change in fair value in interest rate swaps(1) | 8 | 201 | ||||
Income taxes on above adjustments | (89) | 205 | ||||
Adjusted net earnings | 18,819 | 11,283 | ||||
Net earnings per share (basic) | 0.14 | 0.12 | ||||
Adjustment for the above | 0.00 | (0.01) | ||||
Adjusted net earnings per share (basic) |
0.14 | 0.11 |
(1) See “Adjusted results in the 2024 fourth quarter Management’s discussion and Analysis”
RECONCILIATION OF NON-IFRS FINANCIAL MEASURES TO IFRS FINANCIAL MEASURES (CONTINUED)
Fiscal 2024 | Fiscal 2023 | |||||
Consolidated results (In thousands of dollars) |
Sugar | Maple Products |
Total | Sugar | Maple Products |
Total |
Gross margin | 150,860 | 25,012 | 175,872 | 144,397 | 21,329 | 165,726 |
Total adjustment to the cost of sales(1) | 16,571 | (1,020) | 15,551 | (8,375) | (2,020) | (10,395) |
Adjusted gross margin | 167,431 | 23,992 | 191,423 | 136,022 | 19,309 | 155,331 |
Results from operating activities | 84,864 | 12,345 | 97,209 | 86,510 | 8,453 | 94,963 |
Total adjustment to the cost of sales(1) | 16,571 | (1,020) | 15,551 | (8,375) | (2,020) | (10,395) |
Adjusted results from operating activities | 101,435 | 11,325 | 112,760 | 78,135 | 6,433 | 84,568 |
Results from operating activities | 84,864 | 12,345 | 97,209 | 86,510 | 8,453 | 94,963 |
Depreciation of property, plant and equipment, amortization of intangible assets and right-of-use assets | 22,169 | 6,674 | 28,843 | 19,511 | 6,775 | 26,286 |
EBITDA(1) | 107,033 | 19,019 | 126,052 | 106,021 | 15,228 | 121,249 |
EBITDA(1) | 107,033 | 19,019 | 126,052 | 106,021 | 15,228 | 121,249 |
Total adjustment to the cost of sales(1) | 16,571 | (1,020) | 15,551 | (8,375) | (2,020) | (10,395) |
Adjusted EBITDA(1) | 123,604 | 17,999 | 141,603 | 97,646 | 13,208 | 110,854 |
Net earnings | 53,729 | 51,789 | ||||
Total adjustment to the cost of sales(1) | 15,551 | (10,395) | ||||
Net change in fair value in interest rate swaps(1) | 1,845 | 523 | ||||
Income taxes on above adjustments | (4,465) | 2,577 | ||||
Adjusted net earnings | 66,660 | 44,494 | ||||
Net earnings per share (basic) | 0.45 | 0.50 | ||||
Adjustment for the above | 0.11 | (0.08) | ||||
Adjusted net earnings per share (basic) | 0.56 | 0.42 | ||||
(1) See “Adjusted results in the 2024 fourth quarter Management’s discussion and Analysis”. |
CONFERENCE CALL AND WEBCAST
Rogers will host a conference call to discuss our fourth quarter of fiscal 2024 results on November 28, 2024, starting at 8:00 ET. To participate, please dial 1-800-717-1738. To access the live webcast presentation, please click on the link below:
A recording of the conference call will be accessible shortly after the conference, by dialing 1-888-660- 6264, access code 67841#. This recording will be available until December 28, 2024. A live audio webcast of the conference call will also be available via www.LanticRogers.com.
ABOUT ROGERS SUGAR
Rogers is a corporation established under the laws of Canada. The Corporation holds all of the common shares of Lantic and its administrative office is in Montréal, Québec. Lantic operates cane sugar refineries in Montréal, Québec and Vancouver, British Columbia, as well as the only Canadian sugar beet processing facility in Taber, Alberta. Lantic also operate a distribution center in Toronto, Ontario. Lantic’s sugar products are mainly marketed under the “Lantic” trademark in Eastern Canada, and the “Rogers” trademark in Western Canada and include granulated, icing, cube, yellow and brown sugars, liquid sugars, and specialty syrups. Lantic owns all of the common shares of TMTC and its head office is headquartered in Montréal, Québec. TMTC operates bottling plants in Granby, Dégelis and in St-Honoré-de-Shenley, Québec and in Websterville, Vermont. TMTC’s products include maple syrup and derived maple syrup products supplied under retail private label brands in approximately fifty countries and sold under various brand names.
For more information about Rogers please visit our website at www.LanticRogers.com.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This report contains statements or information that are or may be “forward-looking statements” or “forward-looking information” within the meaning of applicable Canadian securities laws. Forward-looking statements may include, without limitation, statements and information which reflect our current expectations with respect to future events and performance. Wherever used, the words “may,” “will,” “should,” “anticipate,” “intend,” “assume,” “expect,” “plan,” “believe,” “estimate,” and similar expressions and the negative of such expressions, identify forward-looking statements. Although this is not an exhaustive list, we caution investors that statements concerning the following subjects are, or are likely to be, forward-looking statements:
- Future demand and related sales volume for refined sugar and maple syrup;
- our LEAP Project;
- future prices of Raw #11;
- natural gas costs;
- beet sugar production forecast for our Taber facility;
- the level of future dividends;
- the status of government regulations and investigations; and
- projections regarding future financial performance.
Forward-looking statements are based on estimates and assumptions made by us in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable in the circumstances, but there can be no assurance that such estimates and assumptions will prove to be correct. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Actual performance or results could differ materially from those reflected in the forward-looking statements, historical results or current expectations. Readers should also refer to the section “Risks and Uncertainties” in the MD&A for additional information on risk factors and other events that are not within our control. These risks are also referred to in our Annual Information Form in the “Risk Factors” section.
Although we believe that the expectations and assumptions on which forward-looking information is based are reasonable under the current circumstances, readers are cautioned not to rely unduly on this forward-looking information as no assurance can be given that it will prove to be correct. Forward-looking information contained herein is made as at the date of this press release and we do not undertake any obligation to update or revise any forward-looking information, whether a result of events or circumstances occurring after the date hereof, unless so required by law.
FOR FURTHER INFORMATION
Mr. Jean-Sébastien Couillard
Vice President of Finance, Chief Financial Officer and Corporate Secretary
Phone: (514) 940-4350
Email: jscouillard@lantic.ca
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Surgical Dental Loupe and Camera Market to Grow 9.3% CAGR, Reaching $1.52 Billion by 2034 | Fact.MR Report
Rockville, MD, Nov. 28, 2024 (GLOBE NEWSWIRE) — Visibility of dental anatomical components has improved drastically with several technological improvements in surgical loupes, such as magnifying lenses and ergonomic designs, which are enabling more accurate diagnosis and treatment. The global surgical dental loupe and camera market is estimated to reach a valuation of US$ 625.9 million in 2024 and increase to US$ 1.52 billion by the end of 2034.
When loupes are combined with dental cameras, they enable the capture of high-definition pictures and films of oral health issues. Patients’ preference for minimally invasive dental procedures for faster recovery and improved outcomes is driving demand for surgical dental loupes and cameras worldwide.
Dental loupes, cameras, and similar devices enhance security in surgical procedures and lead to optimal clinical outcomes. This is driving their extensive adoption worldwide. The growing emphasis on precision dentistry has made dental loupes and cameras indispensable for dentists and other dental professionals, thus fueling market expansion.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10048
Key Takeaways from Market Study
- The global surgical dental loupe and camera market is projected to expand at 3% CAGR through 2034.
- North America is expected to account for 43% of the global market share by 2034.
- The East Asia market is forecasted to reach a valuation of US$ 287 million by the end of 2034.
- Based on product, sales of surgical loupes are projected to rise at 4% CAGR through 2034.
- Dental clinics are estimated to generate revenue of US$ 318.6 million in 2024.
- Sales of clip-on loupes are projected to reach a valuation of US$ 1.06 billion by the end of 2034.
- The market in South Korea is forecasted to expand at a CAGR of 12.8% through 2034.
“The adoption of surgical dental loupes and cameras are increasing as they are helping ensure procedural accuracy, better clinical results, and mainly patient satisfaction,” says a Fact.MR analyst.
Leading Players Driving Innovation in the Surgical Dental Loupe and Camera Market:
Key industry participants like ErgonoptiX, Carl Zeiss Meditec AG, Rose Micro Solutions, SheerVision Incorporated, North-Southern Electronics Limited, L.A. Lens, Carl Zeiss Meditec AG, Designs for Vision, Inc., Carl Zeiss Meditec AG, Orascoptic, Carl Zeiss Meditec AG, PeriOptix, Inc., Carl Zeiss Meditec AG, SurgiTel, Enova Illumination, Carl Zeiss Meditec AG, and Xenosys Co., Ltd., etc. are driving the surgical dental loupe and camera industry.
Growing Demand for Minimally Invasive Dental Procedures
Surgical dental loupes and cameras are becoming more and more necessary tools as the number of minimally invasive treatments performed in hospitals is rising. These instruments are essential for carrying out delicate procedures with greater precision and efficiency. Hospitals significantly contribute to the growth of the surgical dental loupe and camera market due to their high volume of surgeries, embrace of modern technology, and expanding financial resources.
Surgical Dental Loupe and Camera Industry News:
Market players are prioritizing expanding their product portfolios, aiming to offer a diverse range of surgical dental loupes and cameras. They are also focusing on developing innovative solutions, such as lightweight loupes with integrated cameras, often paired with dental lighting, to enhance visibility and deliver superior clinical outcomes.
- In April 2023, NuEyes launched NuLoupes, a cutting-edge smart glasses solution for the surgical and dental loupe market. NuLoupes replaces fixed magnification with high-resolution, variable digital magnification, providing physicians with enhanced adaptability and a wider field of view. Featuring NuEyes’ patented camera technology, these loupes deliver 3D stereoscopic imagery with minimal delay.
- Earlier, in July 2019, Orascoptic introduced Tru Color Technology, a groundbreaking advancement enabling 90 CRI lighting in an LED headlamp mounted on a loupe. This innovation delivers color accuracy comparable to natural sunlight, allowing for exceptionally precise visual interpretation.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=S&rep_id=10048
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the surgical dental loupe and camera market, presenting historical demand data (2018 to 2023) and forecast statistics for 2024 to 2034.
The study divulges essential insights into the market based on product (surgical loupes, surgical headlights, surgical cameras), modality (clip-on loupes, head band-mounted loupes), and end user (hospitals, dental clinics, ambulatory surgical centers), across six major regions of the world (North America, Europe, East Asia, Latin America, South Asia & Oceania, and MEA).
Check out More Related Studies Published by Fact.MR Research:
Nonmydriatic handheld fundus cameras market is projected to increase from a valuation of US$ 140 million in 2022 to US$ 190 million by the end of 2026.
Surgical loupe and camera market size is projected to increase from a valuation of US$ 752 million in 2024 to US$ 1.82 billion by 2034.
Dental cameras market currently accounts for a valuation of US$ 2.3 billion and is expected to reach US$ 4 billion by the end of 2027. Worldwide demand for dental cameras is predicted to increase at a stupendous CAGR of 11.7% from 2022 to 2027.
Endoscopy cameras market is valued at US$ 1.3 billion and is projected to reach a value of US$ 2.15 billion by the end of 2027.
Dental braces market is projected to increase from a valuation of US$ 4.38 billion in 2024 to US$ 8.37 billion by the end of 2034. Sales of dental braces has been evaluated to rise at a CAGR of 6.7% from 2024 to 2034.
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Remember James Howells Who Lost His Hard Drive With 8,000 Bitcoins Now Worth $760M? His Ex-Girlfriend Reveals It Was She Who Threw It Away
James Howells might go down in history books as one of the unluckiest people ever, having discarded hundreds of millions of dollars in Bitcoin BTC/USD accidentally.
But a new twist in this decade-old bizarre saga revealed that it was not him but his ex-girlfriend who unintentionally threw the fortune away.
What Happened: Halfina Eddy-Evans confessed during a Monday interview with the Daily Mail that she threw away the hard drive containing 8,000 Bitcoin at the request of Howells. She was adamant that the loss was not her fault, as she did so at Howells’ request.
Halfina said Howells “begged” her to dispose of some “unwanted belongings,” in a black sack, which, unknown to her, included the hard drive.
“I thought he should be running his errands, not me, but I did it to help out,” Howells said.
Halfina said that the blame for losing Bitcoins shouldn’t be fixed on her, though she hoped Howells would succeed in retrieving the drive.
See Also: Crypto Analyst Flags Convertible Debt-Induced Liquidation Risk To Michael Saylor’s MicroStrategy
Why It Matters: This revelation added a new layer to the unfortunate story of Howells, who has been waging a long battle to recover his fortune.
A Wales-based software engineer, Howells, sued the Newport City Council for approximately $647 million in damages for repeatedly denying his request to excavate the landfill site housing the discarded hard drive.
He has even assembled a team of specialists to excavate at no cost to the council and proposed giving the council 10% of the recovered coins’ value.
The 8,000 Bitcoins would be worth $797 million at the all-time high price of 99,645 recorded recently and $765.9 million at the current market price of $95.736.86.
Read Next:
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Emulsifiers Market for Personal Care Applications to Reach $3.0 Billion by 2034, Fueled by Demand for Sustainable and Natural Ingredients | TMR
Wilmington, Delaware, Transparency Market Research Inc.-, Nov. 28, 2024 (GLOBE NEWSWIRE) — The global emulsifiers market for personal care applications (パーソナルケア用途向け乳化剤市場), valued at $1.5 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 6.6% between 2024 and 2034, reaching $3.0 billion by 2034. This growth is driven by the increasing demand for eco-friendly, sustainable, and bio-based emulsifiers, as well as a rise in the innovation of personal care products.
Emulsifiers play a critical role in personal care formulations by creating stable mixtures of water and oil. They are essential in products like lotions, shampoos, and moisturizers, and their demand is rising due to a growing shift toward natural, organic, and clean-label personal care products. Consumers are increasingly seeking products that are free of synthetic chemicals, and this has led to the increased use of bio-based emulsifiers made from renewable resources such as plant oils and polysaccharides.
Request your complimentary sample report today! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86370
Key Market Drivers
- Green Chemistry and Bio-based Products
-
- Consumers are opting for clean-label products, driving the use of bio-based emulsifiers. These ingredients are derived from renewable, sustainable sources and are biodegradable, making them environmentally friendly.
- Green chemistry principles are becoming more important in personal care product formulations, focusing on reducing environmental impact while maintaining product efficacy.
- Innovation in Personal Care
-
- Emulsifiers are key to the development of multifunctional personal care products such as 2-in-1 cleansers and hybrid skincare formulas. This has led to increased demand for high-performance emulsifiers that can stabilize complex formulations.
- The rise of niche personal care categories such as anti-aging products, sensitive skin solutions, and vegan cosmetics is driving the demand for customized emulsifiers.
- Regulatory Push for Natural Ingredients
-
- Increasing regulations and certifications for natural and organic personal care products in regions like Europe and North America are encouraging manufacturers to adopt bio-based emulsifiers.
- Certifications like ECOCERT and COSMOS for organic products are influencing the growth of the market, as consumers prefer products with these labels.
Market Segmentation
The emulsifiers market for personal care applications is segmented based on type, ionic nature, and application:
- By Type:
-
- Glyceryl Stearate, Lecithin, Polysorbates, Polyglycerol Esters, and others are common emulsifiers used in personal care products. Lecithin is particularly favored for its natural origins in organic cosmetics.
- By Ionic Nature:
-
- Anionic and Non-Ionic emulsifiers are commonly used in skin cleansers and shampoos. Cationic emulsifiers are preferred for their conditioning properties in haircare products.
- By Application:
-
- Major applications include skin cleansers, shampoos, hair conditioners, moisturizers, and other personal care products such as shaving creams and antiperspirants.
Get a Custom Research Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86370
Regional Insights
- North America and Europe lead the market, driven by strict regulatory frameworks that encourage the use of bio-based and natural emulsifiers.
- Asia Pacific is expected to witness significant growth, particularly in countries like China and India, where rising disposable income and increasing awareness of personal care are driving demand.
- Latin America and the Middle East & Africa are emerging markets with untapped growth potential, especially in the natural cosmetics segment.
Competitive Landscape
Key players in the emulsifiers market for personal care applications include BASF SE, Dow, DuPont, Kerry Group, Evonik Industries AG, and Clariant. These companies are focusing on innovation and strategic investments to meet the growing demand for natural, sustainable emulsifiers.
- BASF SE and Dow are leading the way in developing bio-based emulsifiers and other sustainable personal care ingredients. Both companies are investing in eco-friendly solutions and expanding their product portfolios.
- Clariant is focusing on green surfactants and emulsifiers to reduce the environmental footprint of personal care products.
- Evonik Industries is leveraging advanced biotechnological processes to improve the production efficiency and purity of emulsifiers used in cosmetics.
Broader Trends in the Chemicals and Materials Industry
Across the chemicals and materials industry, sustainability continues to be a major focus. Companies are increasingly adopting bio-based and biodegradable ingredients not just in personal care, but also in packaging, coatings, and adhesives. This shift towards sustainability is reshaping various markets, including emulsifiers.
Technological advancements are also playing a key role in driving growth in the emulsifiers market. Innovations such as nanotechnology are improving the delivery and effectiveness of emulsifiers in personal care formulations. These advancements enhance the bioavailability of ingredients in products like skincare creams and hair conditioners.
Mergers and acquisitions are another notable trend in the chemicals sector, as companies seek to strengthen their portfolios in bio-based and specialty ingredients. This consolidation is expected to continue, providing players with the resources to innovate and expand into emerging markets.
Challenges and Opportunities
While the market for bio-based emulsifiers is growing, there are several challenges to overcome. One major challenge is the higher cost of bio-based emulsifiers compared to traditional synthetic alternatives. However, as consumer demand for sustainable products rises, companies are finding ways to improve production efficiency, which could help lower costs in the future.
Supply chain issues, particularly in sourcing natural raw materials like lecithin and palm oil, can also disrupt production. However, these challenges also present opportunities for companies to explore new sources of sustainable ingredients and invest in local sourcing to ensure a steady supply.
Emerging markets in Asia-Pacific and Latin America present significant growth opportunities, driven by increased demand for personal care products and a rising middle class. Additionally, the growing trend toward vegan and organic cosmetics provides companies with opportunities to develop new emulsifier solutions tailored to these product categories.
Looking Ahead
The emulsifiers market for personal care applications is poised for continued growth as consumers increasingly demand sustainable, natural, and multifunctional products. With the market expected to reach $3.0 billion by 2034, companies that invest in bio-based emulsifiers, sustainable sourcing, and innovative product development will be well-positioned to capture a significant share of the market.
In conclusion, the emulsifiers market for personal care applications is at a turning point, with sustainability, innovation, and consumer demand for natural ingredients driving its growth. The market is set to expand significantly in the coming years, offering opportunities for both established companies and new entrants to capitalize on the rising demand for eco-friendly personal care products.
For more insights into market trends, competitive strategies, and emerging opportunities, buy this research report from Transparency Market Research: https://www.transparencymarketresearch.com/checkout.php?rep_id=86370<ype=S
Trending Research Reports in the Chemicals and Materials Industry
- Shape Memory Foam Market (形の記憶泡の市場): Estimated to advance at a CAGR of 12.9% from 2024 to 2034 and reach US$ 52.9 Bn by the end of 2034
- U.S. Acoustics Market (Marché Américain de l’Acoustique): Projected to grow at a CAGR of 5.2% from 2024 to 2034 and reach US$ 2.3 Bn by the end of 2034
Top of Form
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Is Intel Stock a Buy Now?
It’s been a tough year for Intel (NASDAQ: INTC). Its stock price has been essentially cut in half since Jan. 1 and it was booted out of the Dow Jones Industrial Average index in November. To add insult to injury, the company Intel tried to buy in 2005, Nvidia, has gone on to become the second-largest company in the world (based on market cap) and replaced it in the Dow.
But a new year is just around the corner, and with it comes the potential for change. Is Intel poised to rebound in 2025?
Are You Missing The Morning Scoop? Breakfast News delivers it all in a quick, Foolish, and free daily newsletter. Sign Up For Free »
A quick look at Intel’s Q3 numbers shows why the stock has been struggling. The chipmaker saw a 6% year-over-year decline in sales while flipping from adjusted earnings per share (EPS) of $0.41 last year to a per-share loss of $0.46 this year. The semiconductor company’s biggest issue is its third-party foundry business, which it launched in 2021 to help drive growth. Instead, it has been piling up losses.
In Q3, its foundry business saw revenue decline by 8% year over year to $4.4 billion, while the division’s operating losses ballooned to $5.8 billion from $1.8 billion a year ago. The results included a $3.1 billion impairment charge. But even without the impairment, the loss still would have jumped to $2.7 billion.
Moving forward, the company is working to turn its foundry business into an independent subsidiary, which it thinks will help better serve customers and allow for outside funding. It could also be a precursor to the company eventually looking to spin off the business.
Intel expects the foundry business’s operating loss to improve next year as it moves to new nodes with better cost structures and realizes cost savings from its restructuring plans. However, the business got some bad potential news when The New York Times reported that the Biden administration was looking to reduce the $8.5 billion CHIPs Act grant the company was supposed to receive, while awarding rival Taiwan Semiconductor Manufacturing a $6.6 billion grant to build foundries in the U.S. It was revealed on Tuesday that Intel will actually get $7.86 billion. The slightly lower amount was on top of the $3.3 billion Intel has already been awarded through a Department of Defense contract that used CHIPs Act funding.
Outside of its foundry business, Intel’s other businesses have been a mixed bag. On the positive front, its data center and artificial intelligence (AI) segment performed well last quarter, with revenue increasing 9% year over year to $3.3 billion. This is well below the growth of most companies in the data center space, and the company said its Gaudi 3 AI accelerator would not meet 2024 revenue targets.
Is Pfizer Stock in Trouble?
One stock that just can’t seem to catch a break of late is Pfizer (NYSE: PFE). Even though it posted some decent earnings numbers, investors can’t shake the fear that the business is facing daunting headwinds that could send its $145 billion valuation lower in the months and years ahead. And while the markets have done well overall, shares of Pfizer are down some 11% this year.
Is the healthcare stock in big trouble and headed for a greater decline, or are investors perhaps a bit too bearish on the business right now?
Are You Missing The Morning Scoop? Wake up with Breakfast news in your inbox every market day. Sign Up For Free »
Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 billion in 2022), for many investors, it’s still seen as a stock whose best days may be behind it. Demand for its COVID vaccine is waning, significantly, and some investors may worry about a potential change in vaccine policy under the incoming Trump administration.
There’s no denying that the recent election results do appear to be weighing on investors, as Pfizer’s stock has hit a new low since then. Today, the stock is trading at a heavily discounted forward price-to-earnings multiple (based on analyst estimates) of less than 9, which suggests that investors are feeling a bit concerned about Pfizer’s future.
Through the first nine months of the year, Pfizer has generated revenue of $45.9 billion, up 2% overall. While that seems modest, it’s not a bad growth rate when you factor in a steep decline from COVID vaccine sales. Comirnaty, the company’s COVID vaccine, has generated sales of less than $2 billion, which represents a year-over-year decline of 66%.
Stronger results from its specialty care and oncology segments have helped Pfizer overcome headwinds from the vaccine side of its operations.
There could be greater declines in vaccine and COVID sales in the future for Pfizer, regardless of government policy. And that’s because attitudes have shifted in recent years, some people have become more skeptical about vaccines, and unless COVID becomes a significant health concern again, sales could continue to decline. But given the stock’s depressed valuation, I believe those risks have already been priced into its share price.
At this stage, if you’re investing in Pfizer, it’s because you’re optimistic about its growth opportunities outside vaccine-related revenue. The big growth opportunity may be in oncology, especially with Pfizer investing $43 billion to acquire Seagen, which makes antibody-drug conjugates that are more targeted treatment options than chemotherapy. Pfizer has been acquiring multiple businesses in recent years, and with a more diverse pipeline of drugs, those moves can offset the effects that looming patent cliffs and the decline in COVID sales will have on its operations in the long run.
Thanksgiving Day 2024: Is Stock Market Open Today? A Quick Guide To Markets, Banking Hours And What's Closed
Major U.S. indices declined to close lower on Wednesday as the markets headed into the Thanksgiving holiday. Banks, post offices, shipping services, stock markets and all the other over-the-counter markets like bond markets will be closed on Thursday.
What Happened: Despite the holiday, Dow Jones futures will continue trading over the day. Stock exchanges worldwide including Shanghai, Hong Kong, Tokyo, Mumbai, and London would continue to operate. Also, U.S. stock exchanges will re-open on Friday to close early by 1:00 p.m. ET.
Additionally, Walmart, Target and Costco stores will be closed because of the festive celebrations.
Thanksgiving week tends to be historically bullish. However, the S&P 500 Index has gained 0.98% in the last five days, but the Nasdaq 100 Index has slipped by 0.15% in the same period. Russell 2000 Index and NYSE Composite Index on the other hand rose by 4.06% and 2.33% respectively in the last five sessions.
Are Banks Open?
Major financial institutions including Wells Fargo, Bank of America, JPMorgan Chase, and TD Bank will close their branches for the festival.
Federal Reserve banks will also shut operations for the holiday. Customers should verify specific branch hours through their bank’s website or mobile app.
Significance Of The Holiday
Thanksgiving Day is an annual national holiday in the United States and Canada commemorating the harvest and the blessings from the past year.
Image Via Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.